Indivior Pharmaceuticals, Inc 6-K, filed Mar 15, 2024
Indivior Pharmaceuticals, Inc. (INDV)
6-K
2024-03-15
For: 2024-03-15
View Original
Added on
April 10, 2026
About this 6-K
Indivior Pharmaceuticals, Inc filed this 6-K on March 15, 2024.
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
________________________
Washington, D.C. 20549
_____________________
FORM 6-K
_____________________
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
under the Securities Exchange Act of 1934
Date: March 15, 2024
Commission File Number: 001-37835
________________________________________
Indivior PLC
________________________________________
10710 Midlothian Turnpike, Suite 125
North Chesterfield, Virginia 23235
(Address of principal executive office)
_______________________________
Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or Form 40-F
Form
20-F ☒ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper
as permitted by Regulation S-T Rule 101(b)(7): ☐
|
|
EXHIBIT INDEX
|
Exhibit No.
|
Description
of Exhibit
|
|
99.1
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
|
Indivior PLC
|
|
Date: March 15,
2024
|
/s/
Kathryn Hudson
|
|
|
Name:
Kathryn Hudson
|
|
|
Title:
Company Secretary
|
Exhibit 99.1
INDIVIOR PLC (THE 'COMPANY')
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
The Company announces that, subsequent to the delivery of 23,470
shares on March 12, 2024 arising from the exercise and net
settlement of a share option, Christian Heidbreder, a PDMR, sold
23,470 ordinary shares of US$ 0.50 each in the Company
('Shares') on March 13, 2024, March 14, 2024, and March 15,
2024.
The option exercise was in respect of an option over 63,185 Shares
granted on December 29, 2014 at a USD equivalent option price of
US$ 7.024 per share. The Shares were sold at an average
price of US$ 20.84 per share over the three days (6,284 Shares at
US$ 21.06; 15,096 at US$ 20.75; and 2,090 at US$ 20.77
respectively)
Following completion of the transactions, Christian has a
beneficial interest in 92,922 Shares in the Company.
Further information is provided below in accordance with the UK
Market Abuse Regulation.
Kathryn Hudson
Company Secretary
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||
|
a)
|
Name
|
Christian Heidbreder
|
|
|
2
|
Reason for the notification
|
||
|
a)
|
Position/status
|
PDMR - Chief Scientific Officer
|
|
|
b)
|
Initial notification /Amendment
|
Initial notification
|
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
|
a)
|
Name
|
Indivior PLC
|
|
|
b)
|
LEI
|
213800V3NCQTY7IED471
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of US$ 0.50
GB00BN4HT335
|
|
|
b)
|
Nature of the transaction
|
Delivery of Shares arising from exercise of an
option
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
US$ 7.024
|
63,185
|
||
|
d)
|
Aggregated information
- Volume
- Price
- Total
|
n/a
|
|
|
e)
|
Date of the transaction
|
March 12, 2024
|
|
|
f)
|
Place of the transaction
|
Outside a trading venue
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of US$0.50
GB00BN4HT335
|
|
|
b)
|
Nature of the transaction
|
Sale of Ordinary Shares
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
US$ 21.06
|
6,284
|
||
|
d)
|
Aggregated information
- Volume
- Price
- Total
|
n/a
|
|
|
e)
|
Date of the transaction
|
March 13, 2024
|
|
|
f)
|
Place of the transaction
|
The Nasdaq Stock Market LLC (XNAS)
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of US$0.50
GB00BN4HT335
|
|
|
b)
|
Nature of the transaction
|
Sale of Ordinary Shares
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
US$ 20.75
|
15,096
|
||
|
d)
|
Aggregated information
- Volume
- Price
- Total
|
n/a
|
|
|
e)
|
Date of the transaction
|
March 14, 2024
|
|
|
f)
|
Place of the transaction
|
The Nasdaq Stock Market LLC (XNAS)
|
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
|
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of US$0.50
GB00BN4HT335
|
|
|
b)
|
Nature of the transaction
|
Sale of Ordinary Shares
|
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
|
US$ 20.77
|
2,090
|
||
|
d)
|
Aggregated information
- Volume
- Price
- Total
|
n/a
|
|
|
e)
|
Date of the transaction
|
March 15, 2024
|
|
|
f)
|
Place of the transaction
|
The Nasdaq Stock Market LLC (XNAS)
|
|
Indivior PLC's Legal Entity Identifier code is
213800V3NCQTY7IED471.